Rapid Resumption in High-Profile Ozempic MDL as New Judge Takes Over

In a swift move to ensure the continuity of a high-profile case, Judge Marston held a status conference just two weekdays after the U.S. Judicial Panel on Multidistrict Litigation reassigned the Ozempic MDL to her. The MDL had been without a presiding judge for about three weeks following the death of her predecessor, Judge Pratter, who had overseen the litigation since its coordination in February. The quick resumption of proceedings signifies a commitment to advancing the case without further delay. Further details on this development can be accessed here.